Cormorant Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Cormorant Asset Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-200,000	Closed	-$3.03M	–	73
2019 Q1	$3.03M	Sell	200,000 -45,370	-18%	-$727K	0.2%	57
2018 Q4	$4.21M	Sell	245,370 -4,630	-2%	-$79.2K	0.34%	53
2018 Q3	$3.69M	Sell	250,000 -36,668	-13%	-$650K	0.24%	53
2018 Q2	$6.84M	Hold	286,668	–	–	0.51%	45
2018 Q1	$7.32M	Sell	286,668 -13,332	-4%	-$318K	0.55%	33
2017 Q4	$5.54M	Hold	300,000	–	–	0.58%	36
2017 Q3	$3.15M	Hold	300,000	–	–	0.56%	41
2017 Q2	$3.75M	Hold	300,000	–	–	0.62%	43
2017 Q1	$3.02M	Sell	300,000 -155,515	-34%	-$2.31M	0.44%	50
2016 Q4	$7.09M	Hold	455,515	–	–	0.96%	32
2016 Q3	$8.77M	Hold	455,515	–	–	0.97%	33
2016 Q2	$5.4M	Buy	455,515 +5,515	+1%	+$91.1K	0.77%	42
2016 Q1	$8.17M	Hold	450,000	–	–	1.23%	30
2015 Q4	$12.4M	Hold	450,000	–	–	1.48%	26
2015 Q3	$9.95M	Hold	450,000	–	–	1.59%	23
2015 Q2	$8.03M	Buy	+450,000	New	+$7.78M	1.07%	31

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Cormorant Asset Management's COLL Position: Q2 2019 in Review

Cormorant Asset Management sold out of Collegium Pharmaceutical (COLL) in Q2 2019, closing a stake of 200,000 shares — an estimated $3.03M sold.

Cormorant Asset Management first reported a position in COLL in Q2 2015 and held it in 16 quarters. The position peaked at $12.4M in Q4 2015. 128 funds tracked by Wall St. Rank hold COLL as of Q2 2019.

Cormorant Asset Management reported no remaining Collegium Pharmaceutical position as of Q2 2019 after selling out during the quarter.
Cormorant Asset Management sold 200,000 Collegium Pharmaceutical shares in Q2 2019, an estimated $3.03M.
Cormorant Asset Management first reported a position in Collegium Pharmaceutical in Q2 2015 and held it in 16 quarters.
Cormorant Asset Management's Collegium Pharmaceutical position peaked at $12.4M in Q4 2015.
128 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2019.

Based on Cormorant Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.